RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients
Table 3
Association between risk of AI-related musculoskeletal adverse events and 29 SNPs of RANK, RANKL and OPG.